FDA Approves Journavx Drug to Treat Pain Without Addiction Risk

Jan 31, 2025 - 20:00

FDA Approves Journavx Drug to Treat Pain Without Addiction Risk

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.

Related Posts

Stars ink D Lundkvist, F Bourque to 1-year deals

Stars ink D Lundkvist, F Bourque to 1-year deals

Jun 20, 2025

Stanley Cup ratings drop, lower than 4 Nations

Stanley Cup ratings drop, lower than 4 Nations

Jun 20, 2025

Preds expect Josi for camp after POTS diagnosis

Preds expect Josi for camp after POTS diagnosis

Jun 18, 2025

Bruins sign D Lohrei to 2-year, $6.4M extension

Bruins sign D Lohrei to 2-year, $6.4M extension

Jun 23, 2025

Kessel leaves PWHL's Fleet to coach Princeton

Kessel leaves PWHL's Fleet to coach Princeton

Jun 23, 2025

Blackhawks re-sign Donato to 4-year, $16M deal

Blackhawks re-sign Donato to 4-year, $16M deal

Jun 20, 2025